prepandemic influenza vaccine (h5n1) (split virion, inactivated, adjuvanted) glaxosmithkline biologicals
glaxosmithkline biologicals s.a. - split influenza virus, inactivated, containing antigen: a/vietnam/1194/2004 (h5n1) like strain used (nibrg-14) - influenza, human; immunization; disease outbreaks - vaccines - active immunisation against h5n1 subtype of influenza a virus.this indication is based on immunogenicity data from healthy subjects from the age of 18 years onwards following administration of two doses of vaccine prepared from a/vietnam/1194/2004 nibrg-14 (h5n1) (see section 5.1).prepandemic influenza vaccine (h5n1) (split virion, inactivated, adjuvanted) glaxosmithkline biologicals 3.75 µg should be used in accordance with official guidance.
adjupanrix (previously pandemic influenza vaccine (h5n1) (split virion, inactivated, adjuvanted) glaxosmithkline biologicals)
glaxosmithkline biologicals s.a. - split influenza virus, inactivated, containing antigen: a/vietnam/1194/2004 (h5n1) like strain used (nibrg-14) - influenza, human - vaccines - prophylaxis of influenza in an officially declared pandemic situation. pandemic influenza vaccine should be used in accordance with official guidance.
rotarix vaccine live oral suspension 1.5ml pre-filled syringes
glaxosmithkline uk ltd - human rotavirus rix4414 strain live attenuated - oral suspension
rotarix vaccine live oral suspension 1.5ml tube
glaxosmithkline uk ltd - human rotavirus rix4414 strain live attenuated - oral suspension
adjupanrix (previously pandemic influenza vaccine (h5n1) (split virion, inactivated, adjuvanted) glaxosmithkline biologicals)
glaxosmithkline biologicals s.a. - split influenza virus, inactivated, containing antigen: a/vietnam/1194/2004 (h5n1) like strain used (nibrg-14) - influenza, human, immunization, disease outbreaks - vaccines, - prophylaxis of influenza in an officially declared pandemic situation. pandemic influenza vaccine should be used in accordance with official guidance.,
rotarix
glaxosmithkline nz limited - rotavirus vaccine 1e+006 ccid50 (rix4414 strain, grown in vero cells) - powder with diluent for oral suspension - 1e+006 ccid50 - active: rotavirus vaccine 1e+006 ccid50 (rix4414 strain, grown in vero cells) excipient: amino acids dextran 40 dulbecco's modified eagle medium sorbitol sucrose calcium carbonate water for injection xanthan gum - rotarix is indicated for the prevention of rotavirus gastroenteritis
polio sabin one and three (oral) vaccine
glaxosmithkline pte ltd - virus polio type 1, strain lsc, 2ab; virus polio type 3, strain leon 12a, 1b - suspension - virus polio type 1, strain lsc, 2ab ≥10⁶·˚ccid₅₀; virus polio type 3, strain leon 12a, 1b ≥10⁵·⁸ccid₅₀
monoben 400 tablet
glaxosmithkline bangladesh ltd. - albendazole - tablet - 400 mg
amoxil 250 capsule
glaxosmithkline bangladesh ltd. - amoxicillin - capsule - 250 mg
panadol extra tablet
glaxosmithkline bangladesh ltd. - caffeine + paracetamol - tablet - 65 mg + 500 mg